Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study

Youn H. Kim, Martine Bagot, Pier Luigi Zinzani, Madeleine Duvic, Stephen Morris, Ellen J. Kim, Amy Musiek, Pablo L. Ortiz-Romero, Craig Elmets, Herbert Eradat, Nina Magnolo, Julia Scarisbrick, Stephane Dalle, David C. Fisher, Michi Shinohara, Brian Poligone, Barbara Pro, Pietro Quaglino, Nishitha Reddy, Brigitte DrenoLarisa J. Geskin, Ahmad Halwani, Amit Khot, Marie Beylot-Barry, Neil Korman, Frederick Lansigan, Steven M. Horwitz, Zanetta Lamar, Alison J. Moskowitz, Jillian Wells, Oleg Akilov, Dolores Caballero, Richard Cowan, Reinhard Dummer, Mary Jo Lechowicz, Francine Foss, Lars Iversen, Tomomitsu Miyagaki, Ryan A. Wilcox, Pierluigi Porcu, Maarten Vermeer, Sunil Abhyankar, Yukihiko Kato, Theresa Pacheco, Shigetoshi Sano, Basem William, Timothy Fenske, Noriko Fukuhara, Koji Habe, Toshihisa Hamada, Eiji Kiyohara, Bryone Kuss, Adam Lerner, Lawrence Mark, Javier Munoz, Hiroyuki Okamoto, Christiane Querfeld, Jiro Uehara, Hisashi Uhara, Kentaro Yonekura, Auris Huen, Kensei Tobinai, Yoshiki Tokura, Erin Boh, Jan Peter Nicolay, Hidefumi Wada, Mollie Leoni, Takahiro Ito, Fiona Herr, Lubomir SokolShow 50 moreShow less